nafenopin has been researched along with cyclin d1 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chevalier, S; Roberts, RA | 1 |
1 other study(ies) available for nafenopin and cyclin d1
Article | Year |
---|---|
G1-arrested FaO cells re-enter the cell cycle upon stimulation with the rodent non-genotoxic hepatocarcinogen nafenopin.
Topics: Animals; Butyrates; Carcinogens; Carcinoma, Hepatocellular; CDC2-CDC28 Kinases; Cell Cycle Proteins; Cyclin D1; Cyclin E; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; Down-Regulation; Enzyme Inhibitors; Epidermal Growth Factor; G1 Phase; Microtubule-Associated Proteins; Nafenopin; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Rats; Time Factors; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Tumor Suppressor Proteins | 1999 |